Clark William R, Gao Dayong, Lorenzin Anna, Ronco Claudio
Contrib Nephrol. 2018;194:70-79. doi: 10.1159/000485603. Epub 2018 Mar 29.
For continuous renal replacement therapy (CRRT), the extracorporeal filter provides solute depuration, fluid removal, and control of electrolyte and acid-base balance in critically ill patients with acute kidney injury (AKI). The membranes comprising CRRT filters are almost exclusively based on hollow fiber designs and, while adapted from the chronic hemodialysis field, have features that are specific to the requirements of CRRT nevertheless. In addition, these devices have evolved through the 40 years of CRRT in response to changes in clinical practice and the desire to extend the solute removal spectrum. For some critically ill patients, more targeted removal of specific compounds poorly cleared by standard CRRT can be attempted with techniques based on adsorption. Sorbent hemoperfusion is now being applied more broadly in critically ill patients, especially in those with sepsis and systemic inflammation. In this review, the manner in which CRRT membranes and extracorporeal sorbents have evolved over the past 40 years for the treatment of critically ill patients with AKI and other disorders is described.
对于连续性肾脏替代治疗(CRRT),体外滤器可为急性肾损伤(AKI)的重症患者提供溶质清除、液体清除以及电解质和酸碱平衡的控制。构成CRRT滤器的膜几乎完全基于中空纤维设计,虽然是从慢性血液透析领域改编而来,但仍具有CRRT特定要求的特征。此外,这些设备在CRRT的40年发展历程中不断演变,以响应临床实践的变化以及扩大溶质清除范围的需求。对于一些重症患者,可以尝试采用基于吸附的技术,更有针对性地清除标准CRRT清除效果不佳的特定化合物。吸附性血液灌流目前在重症患者中应用更为广泛,尤其是在脓毒症和全身炎症患者中。在本综述中,描述了CRRT膜和体外吸附剂在过去40年中如何演变,以用于治疗AKI和其他疾病的重症患者。